The University of Chicago Header Logo

Connection

Ravi Salgia to Epithelial-Mesenchymal Transition

Back to Details
This is a "connection" page, showing publications Ravi Salgia has written about Epithelial-Mesenchymal Transition.
Ravi Salgia
Connection Strength
0.217
Epithelial-Mesenchymal Transition
  1. The Mu opioid receptor promotes opioid and growth factor-induced proliferation, migration and Epithelial Mesenchymal Transition (EMT) in human lung cancer. PLoS One. 2014; 9(3):e91577.
    View in: PubMed
    Score: 0.119
  2. Activity of crizotinib (PF02341066), a dual mesenchymal-epithelial transition (MET) and anaplastic lymphoma kinase (ALK) inhibitor, in a non-small cell lung cancer patient with de novo MET amplification. J Thorac Oncol. 2011 May; 6(5):942-6.
    View in: PubMed
    Score: 0.097
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.